References
-
1) Ethyl cinnamate suppresses tumor growth through anti-angiogenesis by attenuating VEGFR2 signal pathway in colorectal cancer.
-
2) Neonatal stress disrupts the glymphatic system development and increases the susceptibility to Parkinson's disease in later life.
-
3) The cuproptosis-related gene glutaminase promotes alveolar macrophage copper ion accumulation in chronic obstructive pulmonary disease.
-
4) SAP130 released by ferroptosis tubular epithelial cells promotes macrophage polarization via Mincle signaling in sepsis acute kidney injury.
-
5) GTS-21 attenuates ACE/ACE2 ratio and glycocalyx shedding in lipopolysaccharide-induced acute lung injury by targeting macrophage polarization derived ADAM-17.
-
6) Gastrodin ameliorates acute pancreatitis by modulating macrophage inflammation cascade via inhibition the p38/NF-κB pathway.
-
7) Silver nanoparticles induce endothelial cytotoxicity through ROS-mediated mitochondria-lysosome damage and autophagy perturbation: The protective role of N-acetylcysteine.
-
8) Tetrahydropalmatine promotes random skin flap survival in rats via the PI3K/AKT signaling pathway.
-
9) Network pharmacology, molecular docking and experimental study of CEP in nasopharyngeal carcinoma.
-
10) Hydrogen gas alleviates acute ethanol-induced hepatotoxicity in mice via modulating TLR4/9 innate immune signaling and pyroptosis.
-
11) Repurposed drug agomelatine is therapeutic against collagen-induced arthritis via iNOS targeting.
-
12) Anti-papillary thyroid carcinoma effects of dioscorea bulbifera L. through ferroptosis and the PI3K/AKT pathway based on network pharmacology and experimental validation.
-
13) In vitro and in vivo protective potential of quercetin-3-glucuronide against lipopolysaccharide-induced pulmonary injury through dual activation of nuclear factor-erythroid 2 related factor 2 and autophagy.
-
14) SiRNA-HIF-1α delivered by attenuated Salmonella enhances the efficacy of Lenvatinib against hepatocellular carcinoma.
-
15) Lycium barbarum L. Balanced intestinal flora with YAP1/FXR activation in drug-induced liver injury.